Sequenom Spikes on Rumors Print E-mail
By Staff and Wire Reports   
Wednesday, 07 October 2009 15:42

Shares of Sequenom, Inc. (NASDAQ:SQNM) spiked up early in Wednesday's trading session and closed up at $3.28 +0.33 (11.19%) after rumors that Sequenom might put itself up for sale.

Last week, Sequenom announced that they fired the CEO and the head of R&D many months after the company had revealed that the results for their Down syndrome had been mishandled.

Sequenom also said Nasdaq and the Office of the U.S. Attorney for the Southern District of California made contact with the Company following its announcements on September 28. The Company has met with representatives of the U.S. attorney and Federal Bureau of Investigation and they said it will cooperate fully with the stock exchange and U.S. attorney.

In April employees mishandled data on its SEQureDx Down syndrome blood test. After a five-month review, Sequenom fired key officers and accepted resignations from three lower-ranking employees. The firings followed an investigation by a special committee of the Company's Board of Directors.




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter